BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 17567834)

  • 21. Three germline mutations in the TP53 gene.
    Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
    Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.
    Palmero EI; Schüler-Faccini L; Caleffi M; Achatz MI; Olivier M; Martel-Planche G; Marcel V; Aguiar E; Giacomazzi J; Ewald IP; Giugliani R; Hainaut P; Ashton-Prolla P
    Cancer Lett; 2008 Mar; 261(1):21-5. PubMed ID: 18248785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
    Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM
    Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'de-novo' TP53 mutation.
    Salmon A; Amikam D; Sodha N; Davidson S; Basel-Vanagaite L; Eeles RA; Abeliovich D; Peretz T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):490-3. PubMed ID: 17572079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin.
    Bendig I; Mohr N; Kramer F; Weber BH
    Cancer Genet Cytogenet; 2004 Oct; 154(1):22-6. PubMed ID: 15381368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations.
    Choong SS; Latiff ZA; Mohamed M; Lim LL; Chen KS; Vengidasan L; Razali H; Abdul Rahman EJ; Ariffin H;
    Clin Genet; 2012 Dec; 82(6):564-8. PubMed ID: 22233476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
    Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN
    J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
    Bougeard G; Sesboüé R; Baert-Desurmont S; Vasseur S; Martin C; Tinat J; Brugières L; Chompret A; de Paillerets BB; Stoppa-Lyonnet D; Bonaïti-Pellié C; Frébourg T;
    J Med Genet; 2008 Aug; 45(8):535-8. PubMed ID: 18511570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
    Pötzsch C; Voigtländer T; Lübbert M
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database.
    Ognjanovic S; Olivier M; Bergemann TL; Hainaut P
    Cancer; 2012 Mar; 118(5):1387-96. PubMed ID: 21837677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.
    Magnusson S; Gisselsson D; Wiebe T; Kristoffersson U; Borg Å; Olsson H
    Pediatr Blood Cancer; 2012 Nov; 59(5):846-53. PubMed ID: 22653678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TP53 germline mutations in adult patients with adrenocortical carcinoma.
    Herrmann LJ; Heinze B; Fassnacht M; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E476-85. PubMed ID: 22170717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Li-Fraumeni syndrome: update, new data and guidelines for clinical management].
    Frebourg T; Abel A; Bonaiti-Pellie C; Brugières L; Berthet P; Bressac-de Paillerets B; Chevrier A; Chompret A; Cohen-Haguenauer O; Delattre O; Feingold J; Feunteun J; Frappaz D; Fricker JP; Gesta P; Jonveaux P; Kalifa C; Lasset C; Leheup B; Limacher JM; Longy M; Nogues C; Oppenheim D; Sommelet D; Soubrier F; Stoll C; Stoppa-Lyonnet D; Tristant H
    Bull Cancer; 2001 Jun; 88(6):581-7. PubMed ID: 11459705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
    Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y
    Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline TP53 mutations and single nucleotide polymorphisms in children.
    Valva P; Becker P; Streitemberger P; Lombardi GM; Rey G; Guzman CA; Preciado MV
    Medicina (B Aires); 2009; 69(1 Pt 2):143-7. PubMed ID: 19414295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families.
    Manoukian S; Peissel B; Pensotti V; Barile M; Cortesi L; Stacchiotti S; Terenziani M; Barbera F; Pasquini G; Frigerio S; Pierotti MA; Radice P; Della-Torre G
    Eur J Cancer; 2007 Feb; 43(3):601-6. PubMed ID: 17224268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-genome sequencing analysis of phenotypic heterogeneity and anticipation in Li-Fraumeni cancer predisposition syndrome.
    Ariffin H; Hainaut P; Puzio-Kuter A; Choong SS; Chan AS; Tolkunov D; Rajagopal G; Kang W; Lim LL; Krishnan S; Chen KS; Achatz MI; Karsa M; Shamsani J; Levine AJ; Chan CS
    Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15497-501. PubMed ID: 25313051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome.
    Wu CC; Shete S; Amos CI; Strong LC
    Cancer Res; 2006 Aug; 66(16):8287-92. PubMed ID: 16912210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.
    Bougeard G; Renaux-Petel M; Flaman JM; Charbonnier C; Fermey P; Belotti M; Gauthier-Villars M; Stoppa-Lyonnet D; Consolino E; Brugières L; Caron O; Benusiglio PR; Bressac-de Paillerets B; Bonadona V; Bonaïti-Pellié C; Tinat J; Baert-Desurmont S; Frebourg T
    J Clin Oncol; 2015 Jul; 33(21):2345-52. PubMed ID: 26014290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family.
    Sherif ZA; Danielsen M
    Cancer Genet Cytogenet; 2006 Jul; 168(1):50-8. PubMed ID: 16772121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.